Oxybutynin

奥昔布宁

Report date: 2026/02/09 20:01:27

Base Information

Drug NameOxybutynin
Drug Alias Name羟丁宁oxybutyninumoxibutininaoxybutynineKentera +[7] 
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsHyperhidrosisSweat Gland DiseasesSkin Diseases +[6] 
Global Approved IndicationsUrinary Bladder, OveractiveUrinary Bladder, Neurogenic
Approved Indications in ChinaUrinary Bladder, OveractiveUrinary Bladder, Neurogenic
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryUnited StatesBrazilChile +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesScience Valley Research InstituteThe University Of California DavisUniversity Of Valparaíso +[6] 
Inactive CompaniesBayer AG
Active IndicationsHyperhidrosisSweat Gland DiseasesSkin Diseases +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeG04BD04
Related LinksWikipediaDrugBankKEGG